Literature DB >> 7021836

Incorporation of 3H-thymidine in Mycobacterium leprae within differentiated human macrophages.

H K Prasad, I Nath.   

Abstract

The factors influencing the incorporation of 3H-thymidine (3H-Tdr) in the DNA of Mycobacterium leprae within macrophages derived from human blood have been evaluated. Fifty strains of M. leprae derived from skin nodules of patients with lepromatous leprosy were studied for their ability to incorporate 3H-Tdr. Control macrophages of the same donor maintained alone, or with autoclaved M. leprae, showed low levels of baseline 3H-Tdr incorporation. During a 15-day period of pulsing, 27 of the M. leprae strains incorporated 3H-Tdr at levels of 216-2834% of the incorporation by control cultures. Significant incorporation was observable by the second week of culture and cumulative increases occurred by the third week. A 24-h pulse with 3H-Tdr was inadequate for a detectable increase. A minimal duration of 4-5 days of continuous pulsing was required to obtain a significant increase in the incorporation of 3H-Tdr. Of the 50 M. leprae strains, 23 (46%) failed to incorporate the radiolabel. This failure was apparently not related to differences in the disease status of patients, to the transport conditions for the biopsies, to morphological indices of the extracted M. leprae or to the origin of the host macrophages.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021836     DOI: 10.1099/00222615-14-3-279

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

Review 1.  Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients.

Authors:  C Cocito; J Delville
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

2.  Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.

Authors:  S Laal; L K Bhutani; I Nath
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

3.  Human T cell proliferative responses to particulate microbial antigens are supported by populations enriched in dendritic cells.

Authors:  A Mittal; I Nath
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

4.  Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses.

Authors:  A Mittal; R S Mishra; I Nath
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  Rapid, radiolabeled macrophage culture method for detection of dapsone-resistant Mycobacterium leprae.

Authors:  I Nath; H K Prasad; M Sathish; K V Desikan; P S Seshadri; C G Iyer
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  Toxic effect of the peroxidase-hydrogen peroxide-halide antimicrobial system on Mycobacterium leprae.

Authors:  S J Klebanoff; C C Shepard
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Radiolabeling of Mycobacterium leprae lipids within schwannoma cells, a potential drug screening system.

Authors:  Y Mistry; N H Antia; R Mukherjee
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  Radiometric macrophage culture assay for rapid evaluation of antileprosy activity of rifampin.

Authors:  A Mittal; P S Seshadri; H K Prasad; M Sathish; I Nath
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.

Authors:  S D Desai; T J Birdi; N H Antia
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Rapid, radiolabeled-microculture method that uses macrophages for in vitro evaluation of Mycobacterium leprae viability and drug susceptibility.

Authors:  A Mittal; M Sathish; P S Seshadri; I Nath
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.